| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| W F Davidson, T Giese, T N Fredrickso. Spontaneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions. The Journal of experimental medicine. vol 187. issue 11. 1998-07-01. PMID:9607923. |
in this report we investigated the possibility that mutations at the fas (lpr) and fasl (gld) loci, which prevent fas-mediated apoptosis and cause an early onset benign lymphoid hyperplasia and autoimmunity, also predispose mice to malignant lymphomas later in life. |
1998-07-01 |
2023-08-12 |
mouse |
| A Kawakami, T Nakashima, M Tsuboi, S Urayama, N Matsuoka, H Ida, Y Kawabe, H Sakai, K Migita, T Aoyagi, M Nakashima, K Maeda, K Eguch. Insulin-like growth factor I stimulates proliferation and Fas-mediated apoptosis of human osteoblasts. Biochemical and biophysical research communications. vol 247. issue 1. 1998-07-01. PMID:9636651. |
both fas expression and the degree of anti-fas igm-induced apoptosis of human osteoblasts was also augmented by igf-i. |
1998-07-01 |
2023-08-12 |
human |
| A Kawakami, T Nakashima, M Tsuboi, S Urayama, N Matsuoka, H Ida, Y Kawabe, H Sakai, K Migita, T Aoyagi, M Nakashima, K Maeda, K Eguch. Insulin-like growth factor I stimulates proliferation and Fas-mediated apoptosis of human osteoblasts. Biochemical and biophysical research communications. vol 247. issue 1. 1998-07-01. PMID:9636651. |
the addition of devd-cho, a specific inhibitor of cpp32, to the culture resulted in a significant inhibition of fas-mediated apoptosis of both unstimulated and igf-i-stimulated osteoblasts, although it did not affect the proliferative response or fas expression. |
1998-07-01 |
2023-08-12 |
human |
| A A Iarilin, E G Bulanova, N I Sharova, V M Budagia. [Apoptosis and thymocyte development (epithelial cells as inducers of thymocyte apoptosis)]. Izvestiia Akademii nauk. Seriia biologicheskaia. issue 2. 1998-06-30. PMID:9609947. |
realization of apoptosis at different stages of the development of t-lymphocytes depends to a varying extent on fas, bcl-2, p53, and other regulators. |
1998-06-30 |
2023-08-12 |
mouse |
| A V Alesenko, A S Solov'ev, A A Terent'ev, A V Khreno. [The role of sphingomyelin cycle products in development of apoptosis mediated by Fas receptors and tumor necrosis factor alpha]. Izvestiia Akademii nauk. Seriia biologicheskaia. issue 2. 1998-06-30. PMID:9609949. |
[the role of sphingomyelin cycle products in development of apoptosis mediated by fas receptors and tumor necrosis factor alpha]. |
1998-06-30 |
2023-08-12 |
Not clear |
| R A Jones, V L Johnson, N R Buck, M Dobrota, R H Hinton, S C Chow, G E Kas. Fas-mediated apoptosis in mouse hepatocytes involves the processing and activation of caspases. Hepatology (Baltimore, Md.). vol 27. issue 6. 1998-06-30. PMID:9620337. |
the mechanism of fas antigen-induced hepatocyte apoptosis was investigated. |
1998-06-30 |
2023-08-12 |
mouse |
| R A Jones, V L Johnson, N R Buck, M Dobrota, R H Hinton, S C Chow, G E Kas. Fas-mediated apoptosis in mouse hepatocytes involves the processing and activation of caspases. Hepatology (Baltimore, Md.). vol 27. issue 6. 1998-06-30. PMID:9620337. |
using a monoclonal antibody directed against the fas antigen, apoptosis was induced in freshly isolated murine hepatocytes within 90 minutes of antibody addition as assessed by plasma membrane bleb formation, chromatin condensation, and dna fragmentation. |
1998-06-30 |
2023-08-12 |
mouse |
| Y Refaeli, L Van Parijs, C A London, J Tschopp, A K Abba. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity. vol 8. issue 5. 1998-06-30. PMID:9620682. |
il-2 increases transcription and surface expression of fas ligand (fasl) and suppresses transcription and expression of flip, the inhibitor of apoptosis. |
1998-06-30 |
2023-08-12 |
mouse |
| Y Refaeli, L Van Parijs, C A London, J Tschopp, A K Abba. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity. vol 8. issue 5. 1998-06-30. PMID:9620682. |
the ability of il-2 to enhance expression of a pro-apoptotic molecule, fasl, and to suppress an inhibitor of fas signaling, flip, likely accounts for the role of this cytokine in potentiating t cell apoptosis. |
1998-06-30 |
2023-08-12 |
mouse |
| P A Hershberger, H He, S A McCarth. In vitro thymocyte maturation is associated with reduced cellular susceptibility to Fas-mediated apoptosis. Cellular immunology. vol 185. issue 2. 1998-06-29. PMID:9636691. |
hyporesponsiveness is overcome by increasing the strength of the fas cross-linking stimulus, leading us to propose that reduced thymocyte susceptibility to apoptosis results from altered fas signaling. |
1998-06-29 |
2023-08-12 |
Not clear |
| P A Hershberger, H He, S A McCarth. In vitro thymocyte maturation is associated with reduced cellular susceptibility to Fas-mediated apoptosis. Cellular immunology. vol 185. issue 2. 1998-06-29. PMID:9636691. |
the block in fas signaling resides proximal to ceramide generation, since fas-hyporesponsive thymocytes are susceptible to ceramide-induced apoptosis. |
1998-06-29 |
2023-08-12 |
Not clear |
| M Koga, Y Hiromatsu, A Jimi, Y Inoue, K Nonak. Possible involvement of Fas-mediated apoptosis in eye muscle tissue from patients with thyroid-associated ophthalmopathy. Thyroid : official journal of the American Thyroid Association. vol 8. issue 4. 1998-06-26. PMID:9588496. |
in order to investigate the possible involvement of apoptosis in the pathogenesis of thyroid-associated ophthalmopathy (tao), we studied the expression of fas, fas ligand (fasl), and bcl-2 in extraocular muscle tissues from patients with tao by immunohistochemistry using monoclonal antibodies against fas, fasl, and bcl-2. |
1998-06-26 |
2023-08-12 |
human |
| I Tinhofer, I Marschitz, M Kos, T Henn, A Egle, A Villunger, R Grei. Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo-1/CD95) ligand+ tumor cells in B chronic lymphocytic leukemia. Blood. vol 91. issue 11. 1998-06-26. PMID:9596676. |
although increased fas receptor expression was significant in both t-lymphocytic subsets, only cd4+ cells from b-cll patients underwent apoptosis after treatment with the agonistic fas antibody ch11. |
1998-06-26 |
2023-08-12 |
Not clear |
| H Rabinowich, T E Reichert, Y Kashii, B R Gastman, M C Bell, T L Whitesid. Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes. The Journal of clinical investigation. vol 101. issue 11. 1998-06-26. PMID:9616229. |
lymphocyte apoptosis induced by fas ligand- expressing ovarian carcinoma cells. |
1998-06-26 |
2023-08-12 |
Not clear |
| T Okamura, M Masuda, Y Arai, C Ishida, K Shudou, H Mizoguch. All-trans retinoic acid modulates Fas antigen expression and affects cell proliferation and apoptosis in combination with anti-Fas monoclonal antibody in the human myeloma cell line, U266B1. Experimental hematology. vol 26. issue 6. 1998-06-24. PMID:9620283. |
all-trans retinoic acid modulates fas antigen expression and affects cell proliferation and apoptosis in combination with anti-fas monoclonal antibody in the human myeloma cell line, u266b1. |
1998-06-24 |
2023-08-12 |
human |
| T Okamura, M Masuda, Y Arai, C Ishida, K Shudou, H Mizoguch. All-trans retinoic acid modulates Fas antigen expression and affects cell proliferation and apoptosis in combination with anti-Fas monoclonal antibody in the human myeloma cell line, U266B1. Experimental hematology. vol 26. issue 6. 1998-06-24. PMID:9620283. |
it has also been reported that myeloma cells express fas antigen, and in some of these cells apoptosis was induced by treatment with anti-fas monoclonal antibody (mab). |
1998-06-24 |
2023-08-12 |
human |
| T Okamura, M Masuda, Y Arai, C Ishida, K Shudou, H Mizoguch. All-trans retinoic acid modulates Fas antigen expression and affects cell proliferation and apoptosis in combination with anti-Fas monoclonal antibody in the human myeloma cell line, U266B1. Experimental hematology. vol 26. issue 6. 1998-06-24. PMID:9620283. |
these results indicate that in u266b1 cells, combined treatment with anti-fas mab and atra enhances the induction of apoptosis by modulating the expression of fas and bcl-2 by atra. |
1998-06-24 |
2023-08-12 |
human |
| K Okamoto, H Asahara, T Kobayashi, H Matsuno, T Hasunuma, T Kobata, T Sumida, K Nishiok. Induction of apoptosis in the rheumatoid synovium by Fas ligand gene transfer. Gene therapy. vol 5. issue 3. 1998-06-22. PMID:9614552. |
induction of apoptosis in the rheumatoid synovium by fas ligand gene transfer. |
1998-06-22 |
2023-08-12 |
mouse |
| K Okamoto, H Asahara, T Kobayashi, H Matsuno, T Hasunuma, T Kobata, T Sumida, K Nishiok. Induction of apoptosis in the rheumatoid synovium by Fas ligand gene transfer. Gene therapy. vol 5. issue 3. 1998-06-22. PMID:9614552. |
to establish further the therapeutic effect of fas-mediated apoptosis on ra taking into consideration safety and practicality, we investigated the effect of cells transfected with human fas ligand (hfasl) gene on proliferating human rheumatoid synovium engrafted in severe combined immunodeficiency (scid-ra) mice. |
1998-06-22 |
2023-08-12 |
mouse |
| U Testa, F Grignani, P Samoggia, C Zanetti, R Riccioni, F Lo Coco, D Diverio, N Felli, C G Passerini, M Grell, P G Pelicci, C Peschl. The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blasts. The Journal of clinical investigation. vol 101. issue 10. 1998-06-19. PMID:9593784. |
furthermore, the fusion protein did not modify fas expression (cd95) or sensitivity to fas-mediated apoptosis. |
1998-06-19 |
2023-08-12 |
Not clear |